`
`UNITED STATES DISTRICT COURT
`DISTRICT OF NEW JERSEY
`
`1-IELSINN HEALTHCARES.A. and
`ROCHEPALO ALTOLLC,
`
`Plaintiffs,
`
`v.
`
`DR. REDDY'S LABORATORIES, LTD.,
`DR. REDDY'S LAB ORA TORIES, INC., TEV A
`PHARMACEUTICALS USA, INC., and TEV A
`PHARMACEUTICAL INDUSTRIES, LTD.,
`
`Defendants.
`
`Civil Action No. 11-3962 (MLC) (DEA)
`(Consolidated)
`
`lion. Mary L. Cooper, U.S.D.J.
`Hon. Douglas E. Arpert, U.S.M.J.
`
`(Filed Electronically)
`
`RECEIVED
`JUN -1 2015
`M
`AT 8:30
`WILLIAM t WALSH CLERK
`
`STIPULATION AND ORDER
`
`WHEREAS, Plaintiffs Helsinn Healthcare S.A. and Roche Palo Alto LLC (collectively,
`
`"Plaintiffs") and Defendants Dr. Reddy's Laboratories, Ltd., Dr. Reddy's Laboratories, Inc.,
`
`Teva Pharmaceuticals USA, Inc., and Teva Pharmaceutical Industries, Ltd. (collectively,
`
`"Defendants") previously submitted briefing regarding the construction of the claim tenn
`
`"pharn1aceutically stable" (see D.I. 88, 92, 94, 96);
`
`WHEREAS, Plaintiffs proposed that this term be construed as "shelf stable for periods
`
`greater than 24 months at room temperature";
`
`WHEREAS, Defendants proposed that this term be construed as "without significant
`
`change in chemical and physical integrity for pharmaceutical use";
`
`WHEREAS, the Court deferred ruling on this issue until it could hear expert testimony
`
`addressing this issue during trial· (see D.l. 1 03 at 77: 15-78 :3);
`
`Dr. Reddy’s Laboratories, Ltd., et al.
`v.
`Helsinn Healthcare S.A., et al.
`U.S. Patent No. 9,(cid:20)(cid:26)(cid:22),(cid:28)(cid:23)(cid:21)
`Reddy Exhibit 1013
`
`Exh. 1013
`
`
`
`Case 3:11-cv-03962-MLC-DEA Document 316 Filed 06/01/15 Page 2 of 3 PageID: 18121
`
`- WHEREAS, during the May 19, 2015 trial management conference, Defendants stated
`
`that, in order to streamline the issues for trial, they will not contest Plaintiff'l' construction- of the
`
`"pham1aceutically stable" claim tenn;
`
`IT ISTIEREBY STIPULATED AND A. GREED by ~nd betwech Plaintiffs and
`
`Defendants',·through their undersigned.counsel, and.subject to the·approval ofthe Court, that the
`
`claim term "pharmaceutically stable" is construed to mean "shelf stable for periods greater than
`
`24 months at room temperature." Defendants reserve the right to appeal the construction of this
`
`term after the trial has been completed.
`
`Respectfully submitted,
`
`Dated: June 1, 2015
`
`By: s/ Charles M. Lizza
`Charles M. Lizza
`William C. Baton
`Sarah A. Sullivan
`SAUL EWING LLP
`One Riverfront Plaza, Suite 1520
`Newark, NJ 07102-5426
`(973) 286-6700
`clizza@saul.com
`wbaton@saul.com
`ssullivan@saul.com
`
`Attorneys.for Plaintiffs
`Helsinn Healthcare S.A. and
`Roche Palo Alto LLC
`
`Of CounseL·
`
`Joseph M. O'Malley, Jr.
`Bruce M. Wexler
`Eric W. Dittmann
`James R. Bliss
`IsaacS. Ashkenazi
`Jason T. Christiansen
`
`By: s/ Michael H. lmbacuan
`Stuart D. Sender
`Michael H. Imbacuan
`Kenneth E. Crowell
`Ellen T. Lowenthal
`H; Howard Wang
`BUDD LARNER, P.C.
`150 John F. Kennedy Parkway
`Short Hills, New Jersey 07078
`(973) 379-4800
`ssender@buddlarner.com
`mimbacuan@buddlarner.com
`kcrowell@budd larner .com
`elowenthal@buddlarner.com
`hwang@buddlarner .com
`
`Attorneys for Defendants
`Dr. Reddy's Laboratories, Ltd. and
`Dr. Reddy's Laboratories, Inc.
`
`By: s/ Mayra V. Tarantino
`Michael E. Patunas
`Mayra V. Tarantino
`LITE DEPALMA GREENBERG, LLC
`Two Gateway Center, 12th Floor
`Newark, NJ 071 02
`
`-2.;.
`
`Exh. 1013
`
`
`
`Case 3:11-cv-03962-MLC-DEA Document 316 Filed 06/01/15 Page 3 of 3 PageID: 18122
`
`Angela C. Ni
`Dana Weir
`PAUL HASTINGS LLP
`75 East 55th Street
`New York, NY 1 0022
`(212)318-6000
`josephomal I ey@paulhastings.com
`brucewexler@paulhastings.com
`ericdittmann@paulhastings.com
`jamesbliss@paulhastings.com
`isaacashkenazi@paulhastings.com
`jasonchristiansen@paulhastings.com
`angelani@paulhastings.com
`danaweir@paulhastings.com
`
`Attorneys.for Plaintiff
`Helsinn Healthcare S.A.
`
`Mark E. Waddell
`LOEB & LOEB LLP
`345 Park Avenue
`New York, NY 10154
`(212) 407-4127
`mwaddell@loeb.com
`
`Attorneys for Plaintiff
`Roche Palo Alto LLC
`
`(973) 623-3000
`mpatunas@litedepalma:.com
`mtarantino@l itedepalma.com
`
`Attorneys for Defendants
`Teva Pharmaceuticals USA; Inc. and
`TevaPharmaceutical Industries Ltd.
`
`Of Counsel:
`
`George C. Lombardi
`Lynn MacDonald Ulrich
`Julia M. Johnson
`Brendan F. Barker
`. Karl· A. Leonard
`WINSTON & STRAWN LLP
`35 West Wacker Drive
`Chicago, IL 60601
`(312) 558-5600
`glombardi@winston.com
`lulrich@winston.com
`JMjohnson@winston.com
`bbarker@winston.com
`kaleonard@winston.com
`
`Jovial Wong
`WINSTON & STRAWN LLP
`1·700 .KStreet
`Washington, DC 20006
`(202) 282-5000
`jwong@winston.com
`
`IT IS SO ORDERED this JE'dayof :JP/tlt.,
`
`2015.
`
`-3-
`
`Exh. 1013